Wedelolactone, a Component from Eclipta prostrata (L.) L., Inhibits the Proliferation and Migration of Head and Neck Squamous Cancer Cells through the AhR Pathway.

Current pharmaceutical biotechnology(2022)

引用 3|浏览5
暂无评分
摘要
Our study identifies wedelolactone as a major active component of Ecliptae prostrata (L.) L. with promising anti-cancer properties against head and neck squamous cancer cells.
更多
查看译文
关键词
AhR,CYP1A1,CYP1B1,Ecliptae prostrata (L.) L,Wedelolactone,head and neck squamous cancer cells
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要